Adipotide, also known as FTPP (CKGGRAKDC-GG-D(KLAKLAK)₂), is a synthetic research peptide designed as a targeted proapoptotic compound that binds to prohibitin receptors on adipose tissue vasculature. Upon receptor engagement, it induces mitochondrial membrane disruption and apoptosis in vascular endothelial cells. Adipotide is utilized in preclinical studies investigating angiogenesis inhibition, vascular remodeling, and adipose tissue metabolism through receptor-mediated peptide targeting.
Sale!
ADIPOTIDE(FTPP) (AP2,AP5,AP10,AP25,AP50)
Adipotide, also known as FTPP or the proapoptotic peptide, is a promising new drug for weight loss and diabetes. It works by targeting and destroying fat cells, leaving the rest of the body unharmed. Studies on primates have shown that adipotide can cause significant weight loss, improve insulin sensitivity, and reduce some of the adverse effects of type 2 diabetes.
Adipotide is a research peptide designed to target fat tissue by acting on blood vessels that supply adipose tissue. The dosing guidance below reflects a weight-based protocol commonly expressed as mcg per lb per dose.
Dosing (Weight-Based):
Reference formula: 4.53 mcg per lb (per dose).
Frequency: Commonly listed as once daily.
| 100–150 | 455–680 mcg | 4.53 mcg/lb |
| 151–200 | 685–905 mcg | 4.53 mcg/lb |
| 201–250 | 910–1150 mcg | 4.53 mcg/lb |
Reviews
There are no reviews yet.